NAM
Nissay Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $16.8M | Buy |
26,417
+2,292
| +10% | +$1.45M | 0.11% | 138 |
|
|
2024
Q4 | $17.2M | Buy |
24,125
+847
| +4% | +$603K | 0.1% | 136 |
|
|
2024
Q3 | $24.5M | Buy |
23,278
+1,921
| +9% | +$2.02M | 0.16% | 99 |
|
|
2024
Q2 | $22.4M | Buy |
21,357
+2,397
| +13% | +$2.52M | 0.15% | 91 |
|
|
2024
Q1 | $18.2M | Buy |
18,960
+4,295
| +29% | +$4.13M | 0.13% | 112 |
|
|
2023
Q4 | $12.9M | Buy |
14,665
+748
| +5% | +$657K | 0.1% | 132 |
|
|
2023
Q3 | $11.5M | Buy |
13,917
+882
| +7% | +$726K | 0.1% | 130 |
|
|
2023
Q2 | $9.37M | Sell |
13,035
-12
| -0.1% | -$8.62K | 0.08% | 146 |
|
|
2023
Q1 | $10.7M | Sell |
13,047
-416
| -3% | -$342K | 0.1% | 136 |
|
|
2022
Q4 | $9.71M | Sell |
13,463
-803
| -6% | -$579K | 0.09% | 141 |
|
|
2022
Q3 | $9.83M | Buy |
14,266
+560
| +4% | +$386K | 0.1% | 124 |
|
|
2022
Q2 | $8.1M | Buy |
13,706
+560
| +4% | +$331K | 0.08% | 144 |
|
|
2022
Q1 | $9.18M | Buy |
13,146
+274
| +2% | +$191K | 0.08% | 148 |
|
|
2021
Q4 | $8.13M | Buy |
12,872
+431
| +3% | +$272K | 0.06% | 184 |
|
|
2021
Q3 | $7.53M | Sell |
12,441
-366
| -3% | -$221K | 0.06% | 176 |
|
|
2021
Q2 | $7.15M | Sell |
12,807
-420
| -3% | -$235K | 0.06% | 183 |
|
|
2021
Q1 | $6.26M | Sell |
13,227
-317
| -2% | -$150K | 0.06% | 185 |
|
|
2020
Q4 | $6.54M | Buy |
13,544
+610
| +5% | +$295K | 0.1% | 168 |
|
|
2020
Q3 | $7.24M | Sell |
12,934
-486
| -4% | -$272K | 0.12% | 137 |
|
|
2020
Q2 | $8.37M | Sell |
13,420
-10,373
| -44% | -$6.47M | 0.16% | 134 |
|
|
2020
Q1 | $11.6M | Sell |
23,793
-14,913
| -39% | -$7.28M | 0.3% | 87 |
|
|
2019
Q4 | $14.5M | Sell |
38,706
-2,424
| -6% | -$910K | 0.32% | 82 |
|
|
2019
Q3 | $11.4M | Buy |
41,130
+6,347
| +18% | +$1.76M | 0.28% | 92 |
|
|
2019
Q2 | $10.9M | Sell |
34,783
-1,229
| -3% | -$385K | 0.28% | 91 |
|
|
2019
Q1 | $14.8M | Sell |
36,012
-998
| -3% | -$410K | 0.39% | 63 |
|
|
2018
Q4 | $13.8M | Buy |
37,010
+386
| +1% | +$144K | 0.42% | 56 |
|
|
2018
Q3 | $14.8M | Buy |
36,624
+2,436
| +7% | +$984K | 0.4% | 57 |
|
|
2018
Q2 | $11.8M | Buy |
34,188
+5,957
| +21% | +$2.06M | 0.35% | 68 |
|
|
2018
Q1 | $9.72M | Buy |
28,231
+4,856
| +21% | +$1.67M | 0.3% | 78 |
|
|
2017
Q4 | $8.79M | Buy |
+23,375
| New | +$8.79M | 0.27% | 91 |
|